Acorn Capital Advisors, Llc
Source: SEC Form 13F · as of Mar 2026Acorn Capital Advisors, Llc holds 20 biotech & pharma companies tracked by BioSniper, totaling $350.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$350.0M
| Company | Shares | Value |
|---|---|---|
| TERNTerns Pharmaceuticals, Inc. | 1,746,264 | $92.1M |
| CGONCG Oncology, Inc. | 1,130,501 | $76.6M |
| URGNUroGen Pharma Ltd. | 1,673,420 | $30.1M |
| PBYIPUMA BIOTECHNOLOGY, INC. | 4,131,299 | $26.4M |
| TRVITrevi Therapeutics, Inc. | 2,144,844 | $25.6M |
| CADLCandel Therapeutics, Inc. | 3,497,948 | $17.2M |
| BCAXBicara Therapeutics Inc. | 643,382 | $12.8M |
| OKUROnKure Therapeutics, Inc. | 2,839,674 | $11.8M |
| JBIOJade Biosciences, Inc. | 786,760 | $11.1M |
| TARAProtara Therapeutics, Inc. | 1,752,115 | $9.1M |
| VSTMVerastem, Inc. | 1,469,153 | $7.8M |
| HELPCYBIN INC. | 1,540,266 | $7.4M |
| LONALeonaBio, Inc. | 634,539 | $6.5M |
| AURAAura Biosciences, Inc. | 595,744 | $4.0M |
| WHWKWhitehawk Therapeutics, Inc. | 1,139,363 | $3.9M |
| CRDFCardiff Oncology, Inc. | 1,762,084 | $2.9M |
| QTTBQ32 Bio Inc. | 315,052 | $2.0M |
| KPTIKaryopharm Therapeutics Inc. | 287,826 | $1.6M |
| JSPRJasper Therapeutics Inc. | 1,411,492 | $1.2M |
| VYNEVYNE Therapeutics Inc. | 1,425 | $855 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.